JO2173B1 - Materix tablet enabling prolonged release of gliclazide after administration by the oral route. - Google Patents

Materix tablet enabling prolonged release of gliclazide after administration by the oral route.

Info

Publication number
JO2173B1
JO2173B1 JO2000165A JOP20000165A JO2173B1 JO 2173 B1 JO2173 B1 JO 2173B1 JO 2000165 A JO2000165 A JO 2000165A JO P20000165 A JOP20000165 A JO P20000165A JO 2173 B1 JO2173 B1 JO 2173B1
Authority
JO
Jordan
Prior art keywords
gliclazide
administration
oral route
materix
prolonged release
Prior art date
Application number
JO2000165A
Other languages
Arabic (ar)
Inventor
هوت دي باروشيه برونو
وثريتش باتريك
مارتن لويس
Original Assignee
ليه لابوراتوريز سيرفييه
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ليه لابوراتوريز سيرفييه filed Critical ليه لابوراتوريز سيرفييه
Priority to JO2000165A priority Critical patent/JO2173B1/en
Application granted granted Critical
Publication of JO2173B1 publication Critical patent/JO2173B1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

THE INVENTION RELATES TO A MATRIX TABLET FOR THE PROLONGED RELEASE OF GLICLAZIDE WHICH ENSURES CONTNUOUS AND CONSISTENT RELEASE OF THE ACTIVE INGREDIENT AFTER ADMINISTRATION BY THE ORAL ROUTE , THE RELEASE BEING INSENSITIVE TO VARIATIONS IN THE PH OF THE DISSOULUTION MEDIUM
JO2000165A 2000-09-27 2000-09-27 Materix tablet enabling prolonged release of gliclazide after administration by the oral route. JO2173B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JO2000165A JO2173B1 (en) 2000-09-27 2000-09-27 Materix tablet enabling prolonged release of gliclazide after administration by the oral route.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JO2000165A JO2173B1 (en) 2000-09-27 2000-09-27 Materix tablet enabling prolonged release of gliclazide after administration by the oral route.

Publications (1)

Publication Number Publication Date
JO2173B1 true JO2173B1 (en) 2003-04-23

Family

ID=48052119

Family Applications (1)

Application Number Title Priority Date Filing Date
JO2000165A JO2173B1 (en) 2000-09-27 2000-09-27 Materix tablet enabling prolonged release of gliclazide after administration by the oral route.

Country Status (1)

Country Link
JO (1) JO2173B1 (en)

Similar Documents

Publication Publication Date Title
GEP20053501B (en) Core Tablet for Controlled Release of Gliclazide after Oral Administration
WO2000041681A3 (en) MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST
HUP0101237A1 (en) Sustained release preparations
ZA200301813B (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them.
NO20011471D0 (en) New oral sustained release formulations
MXPA03003235A (en) Delayed release pharmaceutical formulations.
DE59802670D1 (en) OSMOTIC DRUG RELEASE SYSTEM
BG108516A (en) Pharmaceutical formulation
IL165786A0 (en) Ibuprofen suspension
DK1007006T3 (en) Formulation of the cefadroxil monohydrate tablet
HK1036937A1 (en) Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route.
MXPA03002569A (en) Controlled release formulations for oral administration.
WO2005007137A3 (en) Tablets containing ambroxol
YU8701A (en) New oral formulation
DE60102590D1 (en) PHARMACEUTICAL FORMS FOR TREATING ORAL MYCOSIS
ES2130081B1 (en) TRIMEBUTINE MALEATE TABLET WITH LAMINAR COATING.
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
IL150528A0 (en) Ibuprofen containing active agent preparation
MXPA03005221A (en) Pharmaceutical dronedarone composition for parenteral administration.
HK1045937A1 (en) Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof
MXPA01008348A (en) Microcapsules for sustained release of drugs.
JO2173B1 (en) Materix tablet enabling prolonged release of gliclazide after administration by the oral route.
WO2002024146A3 (en) Methods of decreasing or preventing pain using spicamycin derivatives
ATE357220T1 (en) MODIFIED RELEASE PHARMACEUTICAL COMPOSITION
EG22658A (en) Matrix tablet enabling prolonged release of gliclazide after administration by the oral route